Menu

Speaker

Time slot's time in Taipei (GMT+8)
  •  2024/10/5
  •  Room 301
  •  Type: Physical(video)
  • Lunch Symposium-MSD
  • TIME
  • TOPIC
  • SPEAKER
  • MODERATOR
  • 12:20-13:20(Video)
  • How to optimize the treatment outcome in multidrug-resistant gram-negative infections patient through a novel β-lactam-β-lactamase inhibitor
  • SPEAKER:  Matteo Bassetti
    Italy (義大利)
  • MODERATOR: 
Italy (義大利)
  • Prof. Matteo Bassetti
  • Chief, Infectious Disease Division
  • Ospedale Policlinico San Martino, Genoa, Italy.
Biography:
Medical education
1995: Degree in Medicine at University of Genoa School of Medicine, Genoa, Italy
1999: Specialized in Infectious Diseases at University of Genoa School of Medicine, Genoa, Italy
2001: Post-graduate fellowship in Infectious Diseases at Yale University School of Medicine, New Haven CT, USA
2004: PhD in Infectious Diseases in Solid Organ Transplantation and Infectious Diseases at University of Genoa School Medicine, Genoa, Italy

Academic achievements
2001-2011 Contract Professor of Infectious Diseases at University of Genoa School of Medicine and in the Postgraduate Schools of Infectious Diseases, Hematology and Hygiene if the same university
2011- 2016. Contract Professor of Infectious Diseases at University of Udine School of Medicine and in the Postgraduate School of Hygiene, Haematology, Oncology, Critical Care and Anaesthesiology if the same university
2016-2019. Associate-Professor of Infectious Disease, University of Udine
2019-toda. Full-Professor of Infectious Disease, University of Genoa

Role in international groups/scientific societies
2008: Secretary of the Infectious Diseases Group (IDG) of European Organization for Research and Treatment of Cancer (EORTC).
2011-2016 Treasurer and vice-Chair of the “Critically ill study group” of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID)”.
2016-today : Chair of the “Critically ill study group” of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID)”.
2006-2016: Study coordinator for the “Candidiasis Group” of the ESCMID Fungal Infection Study Group.
2009-2016 Secretary of Working Group on Bone and Skin and Soft Tissue Infections (SSTIs) of International Society of Chemotherpy (ISC)
2014-today Co-chair of Working Group on Abdominal infections of International Society of Chemotherpy (ISC)
Elected member and co-chair of the executive committee of the International Society of Chemotherapy (ISC).
2009-2016 Member of the steering committee of the Italian Society of Infectious Diseases
Commission for bone and Joint Infections, skin and soft tissue infections and endocarditis
2013-2019 Vice-President of the Italian Society of Anti-infective Therapy (SITA)
Elected member (2018-2022) of the International Council of the Immunocompromised Host Society (ICHS).
Since 2019, he has been an elected member of the International Sepsis Forum (ISF).
Member of the executive committee of the National Plan for Combating Antimicrobial Resistance- Antimicrobial Resistance (PNCAR) of the Ministry of Health.
Chair of the Infections in the Critical Patient study group of the leading European infectious diseases society, the European Society of Clinical Microbiology and Infectious Diseases (ESCMID/CIP study group).
2019-today President of the Italian Society of Anti-infective Therapy (SITA)
Member of the following societies: Infectious Diseases Society of America (IDSA),
European Society of Clinical Microbiology and Infectious Diseases (ESCMID),
International Society of Infectious Diseases (ISID), Società Italiana di Chemioterapia
(SIC), Società Italiana di Malattie Infettive e Tropicali (SIMIT) e Società Italiana di Terapia Anti-infettiva (SITA).

Back